JP2023545509A5 - - Google Patents
Info
- Publication number
- JP2023545509A5 JP2023545509A5 JP2023523013A JP2023523013A JP2023545509A5 JP 2023545509 A5 JP2023545509 A5 JP 2023545509A5 JP 2023523013 A JP2023523013 A JP 2023523013A JP 2023523013 A JP2023523013 A JP 2023523013A JP 2023545509 A5 JP2023545509 A5 JP 2023545509A5
- Authority
- JP
- Japan
- Prior art keywords
- heteroaryl
- alkyl
- ring
- aryl
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063091894P | 2020-10-14 | 2020-10-14 | |
| US63/091,894 | 2020-10-14 | ||
| PCT/US2021/055104 WO2022081927A1 (en) | 2020-10-14 | 2021-10-14 | Tricyclic compounds to degrade neosubstrates for medical therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026079082A Division JP2026133474A (ja) | 2020-10-14 | 2026-05-08 | 医学的療法のための、ネオ基質を分解する三環式化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023545509A JP2023545509A (ja) | 2023-10-30 |
| JP2023545509A5 true JP2023545509A5 (cg-RX-API-DMAC10.html) | 2024-10-22 |
| JP7863101B2 JP7863101B2 (ja) | 2026-05-20 |
Family
ID=81208653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523013A Active JP7863101B2 (ja) | 2020-10-14 | 2021-10-14 | 医学的療法のための、ネオ基質を分解する三環式化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240018118A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4228624A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7863101B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230107807A (cg-RX-API-DMAC10.html) |
| CN (2) | CN122277521A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021360596A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3194351A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL302036A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023004369A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022081927A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4717317A3 (en) | 2017-06-20 | 2026-06-03 | C4 Therapeutics, Inc. | N/o-linked degrons and degronimers for protein degradation |
| JP7863100B2 (ja) * | 2020-10-14 | 2026-05-20 | シーフォー セラピューティクス, インコーポレイテッド | Ikzf2又はikzf4を分解する三環式リガンド |
| JP7807110B2 (ja) * | 2021-08-27 | 2026-01-27 | ハンチョウ グルビオ ファーマシューティカル カンパニー,リミティド | イソインドリノン化合物およびその使用 |
| JP2025501056A (ja) | 2021-12-30 | 2025-01-17 | シャンハイ ハンソー バイオメディカル カンパニー リミテッド | 三環系誘導体阻害剤、その製造方法と応用 |
| JP2025531869A (ja) * | 2022-09-09 | 2025-09-25 | イノヴォ セラピューティクス、インコーポレイテッド | CK1αおよびDUAL CK1α/GSPT1分解化合物 |
| WO2024073507A1 (en) | 2022-09-28 | 2024-04-04 | Theseus Pharmaceuticals, Inc. | Macrocyclic compounds and uses thereof |
| KR20250079173A (ko) | 2022-10-03 | 2025-06-04 | 고리츠다이가쿠호진 요코하마시리츠다이가쿠 | 이환성 구조를 갖는 이미다조피리딘 유도체 |
| WO2024096753A1 (en) | 2022-11-02 | 2024-05-10 | Captor Therapeutics S.A. | Nek7 degraders and methods of use thereof |
| WO2024153246A1 (zh) * | 2023-01-20 | 2024-07-25 | 海南先声再明医药股份有限公司 | 取代的三环化合物及其应用 |
| CN120569372A (zh) | 2023-01-24 | 2025-08-29 | 第一三共株式会社 | 经取代的苯化合物 |
| CN117903192A (zh) * | 2023-03-12 | 2024-04-19 | 上海相辉医药科技有限公司 | 一种3-甲氧基异喹啉化合物中间体的制备方法 |
| WO2024259303A1 (en) * | 2023-06-16 | 2024-12-19 | Oncopia Therapeutics, Inc. D/B/A Sk Life Science Labs | Compounds and compositions as cereblon ligands and uses thereof |
| TW202530189A (zh) | 2023-09-29 | 2025-08-01 | 日商第一三共股份有限公司 | 3-苯基丙基胺衍生物 |
| WO2025162410A1 (zh) * | 2024-01-31 | 2025-08-07 | 微境生物医药科技(上海)有限公司 | 新型蛋白降解剂及抗体-蛋白降解剂偶联物 |
| CN121620373A (zh) * | 2024-07-26 | 2026-03-06 | 上海超阳药业有限公司 | 苯并吲哚衍生物的药物组合物、制备方法及用途 |
| TW202615052A (zh) * | 2024-08-27 | 2026-04-16 | 日商第一三共股份有限公司 | 多環性化合物 |
| WO2026064643A1 (en) * | 2024-09-20 | 2026-03-26 | Plexium, Inc. | Compounds, compositions, and methods of use thereof |
| WO2026065268A1 (en) * | 2024-09-29 | 2026-04-02 | Biofront Ltd | Novel conjugates for protein degradation, compositions comprising the same, and methods of using the same |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007517766A (ja) * | 2003-09-24 | 2007-07-05 | コンビナトアールエックス インコーポレーティッド | 薬物の組み合わせを投与するための治療法 |
| JP6815318B2 (ja) * | 2014-12-23 | 2021-01-20 | ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド | 二官能性分子によって標的化タンパク質分解を誘導する方法 |
| CN111662226B (zh) * | 2015-01-28 | 2022-03-18 | 中国科学院广州生物医药与健康研究院 | 一种2-氧代-1,2-二氢苯并[cd]吲哚类化合物 |
| WO2017197056A1 (en) * | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Bromodomain targeting degronimers for target protein degradation |
| IL319363A (en) * | 2017-01-31 | 2025-05-01 | Arvinas Operations Inc | Cervalon ligands and bifunctional compounds containing them |
| US10738056B2 (en) * | 2017-09-15 | 2020-08-11 | Aduro Biotech Inc. | Pyrazolopyrimidinone compounds and uses thereof |
| JP2021512153A (ja) * | 2018-01-26 | 2021-05-13 | イエール ユニバーシティ | タンパク質分解のイミド系モジュレーターおよび使用方法 |
| US10905684B2 (en) * | 2018-06-13 | 2021-02-02 | Biotheryx, Inc. | Aminoamide compounds |
| US12030892B2 (en) * | 2018-06-29 | 2024-07-09 | Dana-Farber Cancer Institute, Inc. | CRBN modulators |
| AR116109A1 (es) * | 2018-07-10 | 2021-03-31 | Novartis Ag | Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos |
| CA3123519A1 (en) * | 2019-02-15 | 2020-08-20 | Novartis Ag | Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof |
| KR102947433B1 (ko) * | 2019-04-12 | 2026-04-06 | 씨4 테라퓨틱스, 인코포레이티드 | 이카로스 및 아이올로스의 트리시클릭 분해제 |
| CN116194453A (zh) * | 2019-12-20 | 2023-05-30 | 卡里科生命科学有限责任公司 | 蛋白质酪氨酸磷酸酶降解剂及其使用方法 |
| AU2021322285B2 (en) * | 2020-08-07 | 2026-08-13 | C4 Therapeutics, Inc. | Advantageous therapies for disorders mediated by Ikaros or Aiolos |
| JP7863100B2 (ja) * | 2020-10-14 | 2026-05-20 | シーフォー セラピューティクス, インコーポレイテッド | Ikzf2又はikzf4を分解する三環式リガンド |
| IL302037A (en) * | 2020-10-14 | 2023-06-01 | C4 Therapeutics Inc | Tricyclic heterobifunctional compounds for degradation of targeted proteins |
-
2021
- 2021-10-14 CA CA3194351A patent/CA3194351A1/en active Pending
- 2021-10-14 WO PCT/US2021/055104 patent/WO2022081927A1/en not_active Ceased
- 2021-10-14 CN CN202610392389.1A patent/CN122277521A/zh active Pending
- 2021-10-14 AU AU2021360596A patent/AU2021360596A1/en active Pending
- 2021-10-14 JP JP2023523013A patent/JP7863101B2/ja active Active
- 2021-10-14 EP EP21881144.6A patent/EP4228624A4/en active Pending
- 2021-10-14 IL IL302036A patent/IL302036A/en unknown
- 2021-10-14 KR KR1020237015799A patent/KR20230107807A/ko active Pending
- 2021-10-14 MX MX2023004369A patent/MX2023004369A/es unknown
- 2021-10-14 CN CN202180079148.7A patent/CN116457339A/zh active Pending
-
2023
- 2023-04-14 US US18/134,990 patent/US20240018118A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3188418B2 (ja) | 3−(縮合環置換)フェニル−5β−アミドメチルオキサゾリジン−2−オン類および3−(窒素原子置換)フェニル−5β−アミドメチルオキサゾリジン−2−オン類 | |
| TW401402B (en) | Novel N-heterocyclyl sulfonamides and pharmaceutical composition and preparation process thereof | |
| AU2004299413C1 (en) | Novel oxazolidinone derivatives | |
| JP3176626B2 (ja) | 抗菌剤として有用な置換アリール−およびヘテロアリールフェニルオキサゾリジノン類 | |
| JP2022538588A (ja) | NaV1.8阻害剤としての2,3-ジヒドロキナゾリン化合物 | |
| Burkholder et al. | The syntheses of nonnucleoside, HIV-1 reverse transcriptase inhibitors containing a CF2 group: The SRN1 reactions of 2-(bromodifluoromethyl) benzoxazole with the anions derived from heterocyclic thiols and phenolic compounds | |
| JP2025505200A5 (cg-RX-API-DMAC10.html) | ||
| JPS60228477A (ja) | 2‐アルコキシ‐n‐(1‐アザビシクロ[2,2,2]オクト‐3‐イル)ベンズアミド類およびチオベンズアミド類 | |
| HRP960159A2 (en) | Benzocyclopentane oxazolidinones containing heteroatoms | |
| JP2020534263A5 (cg-RX-API-DMAC10.html) | ||
| CA2672616A1 (en) | Novel oxadiazole compounds | |
| KR20230019880A (ko) | Lpa 수용체 길항제 및 이의 용도 | |
| JP2011527686A5 (cg-RX-API-DMAC10.html) | ||
| JP2025505644A5 (cg-RX-API-DMAC10.html) | ||
| JP2024544060A5 (cg-RX-API-DMAC10.html) | ||
| JP2021536510A5 (cg-RX-API-DMAC10.html) | ||
| JP2006510729A (ja) | 抗菌剤 | |
| CN105073724A (zh) | 作为钾离子通道抑制剂的2,3-二氮杂萘类化合物 | |
| US20020143009A1 (en) | Novel bicyclic oxazolidinones as antibacterial agents | |
| CN106536482A (zh) | 具有抗hiv作用的苯基和叔丁基乙酸取代的吡啶酮 | |
| JPH0236184A (ja) | イミダゾキノキサリン化合物、その製造方法並びにその使用 | |
| AU2001247540B2 (en) | Novel benzosultam oxazolidinone antibacterial agents | |
| JPH0859621A (ja) | 置換キノリン誘導体、それらの製造方法およびそれらの使用 | |
| AU2002238688B2 (en) | Aryl carbamate derivatives, preparation and use thereof | |
| AU2001247540A1 (en) | Novel benzosultam oxazolidinone antibacterial agents |